Effects of rat fetuin on stimulation of bone resorption in the presence of parathyroid hormone

Bioscience, Biotechnology and Biochemistry

Volumn 63, Issue 8, 1999, Pages 1383-1391

  Nakamura, Osamu ^a,b   Ahsan Kazi, Jamil ^a,c   Ohnishi, Tomokazu ^a   Arakaki, Naokatu ^a,d   Shao, Qing ^a,e   Kajihara, Takehiro ^a   Daikuhara, Yasushi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Bone resorption; Cathepsin L; Parathyroid hormone; Rat fetuin; 2 HS glycoprotein

Indexed keywords

ALPHA FETOPROTEIN; CATHEPSIN; CATHEPSIN L; COLLAGEN; CYSTEINE PROTEINASE; PARATHYROID HORMONE; PROTEINASE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CULTURE MEDIUM; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; OSTEOLYSIS; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PREGNANCY; STIMULATION;

ALPHA-FETOPROTEINS; ANIMALS; BONE RESORPTION; CATHEPSINS; COLLAGEN; CULTURE MEDIA, CONDITIONED; CYSTEINE ENDOPEPTIDASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOPEPTIDASES; FEMALE; MICE; MICE, INBRED ICR; PARATHYROID HORMONE; PHOSPHORYLATION; PREGNANCY; STIMULATION, CHEMICAL;

EID: 0033174905     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.63.1383     Document Type: Article

References (61)

1. Heinegärd, D., Hultenby, K., Oldberg, Ä., Reinholt, F., and Wendel, M., Macromolecules in bone matrix. Connect. Tissue Res., 21, 3-14 (1989).
2. 2-HS glycoprotein and is synthesized by both hepatocyte and osteoblasts. J. Biol. Chem., 266, 14636-1464 (1991).
3. 2-HS glycoprotein and bovine fetuin. J. Bone Miner. Res., 8, 367-377 (1993).
4. 2-HS glycoprotein. Method. Enzymol., 163, 431-444 (1988).
5. 2-HS glycoprotein. Similarity to the disulfide bridge structures of cystα-tins and kininogens. J. Biol. Chem., 264, 14121-14128 (1989).
6. Hu, B., Coulson, L., Moyer, B., and Price, P. A., Isolation and molecular cloning of a novel bone phosphoprotein related in sequence to the cystatin family of thiol protease inhibitors. J. Biol. Chem., 270, 431-436 (1995).
7. 2-HS glycoprotein and bovine fetuin. Biochem. J., 274, 899-902 (1991).
8. Rauth, G., Pöchke, O., Fink, E., Eulitz, M., Tippmer, S., Kellerer, M., Häring, H.-U., Nawratil, P., Hassemann, M., Jahnen-Dechent, W., and Miiller-Esterl, W., The nucleotide and partial amino acid sequences of the rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor. Eur. J. Biochem., 204, 523-529 (1992).
9. Auberger, P., Falquerho, L., Contreres, J. O., Pages, G., Le Cam, G., Rossi, B., and Le Cam, A., Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and antimitogenic activity. Cell, 58, 631-640 (1989).
10. Tsubouchi, H., Gohda, E., Strain, A. J., and Daikuhara, Y., The role of HGF-SF in animal and human hepatic physiology and pathology. In “Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the C-Met Receptor,” eds. Goldberg, I. D. and Rosen, E. M., Birkhäuser, Basel, pp. 251-274 (1993).
11. Ohnishi, T., Nakamura, O., Arakaki, N., and Daikuhara, Y., Effect of phosphorylated rat fetuin on the growth of hepatocyte in primary culture in the presence of hepatocyte growth factor-scatter factor (HGF/SF). Evidence that phosphorylated rat fetuin is a natural modulator of HGF/SF. Eur. J. Biochem., 243, 753-761 (1997).
12. Rohrlich, S. T. and Rifkin, D. B., Isolation of the major serine protease inhibitor from the 5-day serum-free conditioned medium of human embryonic lung cells and demonstration that it is fetuin. J. Cell Physil., 109, 1-15 (1981).
13. Hsu, C. C. S. and Floyd, M., Lymphocyte stimulating and immunochemical properties of fetuin preparations. Protides Biol. Fluids Proc. Colloq., 24, 295-302 (1976).
14. Cayatte, A. J., Kumbla, L., and Subbiah, M. T. R., Marked acceleration of exogenous fatty acid incorporation into cellular triglyceride by fetuin. J. Biol. Chem., 265, 5883-5888 (1990).
15. Kumbla, L., Cayatte, A. J., and Subbiah, M. T. R., Association of a lipoprotein-like particle with bovine fetuin. FASEB J., 3, 2075-2080 (1989).
16. Fisher, D. A. and Lam, R. W., Thyroid hormone binding by bovine and ovine fetuin. Endocrinology, 94, 49-54 (1974).
17. Abdullah, M., Crowell, J. A., Tres, L. L., and Kierszenbaum, A. L., Fetuin: A serum component associated with rat Sertoli and spermatogenic cells in coculture. J. Cell Physiol., 127, 463-472 (1986).
18. 2-HS glycoprotein and its accumulation in bone. Nature, 262, 226-227 (1976).
19. 2-HS Glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. J. Biol. Chem., 271, 20789-20796 (1996).
20. Wilson, J. M., Ashton, B. A., and Triffitt, J. T., The interaction of a component of bone organic matrix with the mineral phase. Calcif. Tissue Int., 22, 458-460 (1977).
21. 2-HS glycoprotein is a transforming growth factor-β type II receptor mimic and cytokine antagonist. J. Biol. Chem., 271, 12755-12761 (1996).
22. 2-HS glycoprotein: Expression in chondrocytes and augmentation of alkaline phosphatase and phospholipase A2 activity. Bone, 12, 7-15 (1991).
23. Malone, J. D., Teitelbaum, S. L., Griffin, G. L., Senior, R. M., and Kahn, A. J. Recruitment of osteoclast precursors by purified bone matrix constituents. J. Cell Biol., 92, 227-230 (1982).
24. 2-HS glycoprotein modulates in vitro bone resorption. J. Clin. Endocrin. Metabol., 66, 187-192 (1987).
25. Nakamura, O., Gohda, E., Ozawa, M, Senba, I., Miyazaki, H., Murakami, T., and Daikuhara, Y., Immunohistochemical studies with a monoclonal antibody on the distribution of phos-phophoryn in predentin and dentin. Calcif. Tissue Int., 37, 491-500 (1985).
26. Nakama, T., Nakamura, O., Daikuhara, Y., and Semba, T., A monoclonal antibody against dentin phosphophoryn recognizes a bone protein(s) appearing at the beginning of ossification. Calcif. Tissue Int., 43, 263-267 (1988).
27. 3 and lipopolysaccharides. Calcif. Tissue Int., 39, 28-34 (1986).
28. Kakegawa, H., Nikawa, T., Tagami, K., Kamioka, H., Sumitani, K., Kawata, T., Drobnic-Kosorok, M., Lenarcic, B., Turk, V., and Katunuma, N., Participation of cathepsin L on bone resorption. FEBS Lett., 321, 247-250 (1993).
29. Barrett, A. J. and Kirschke, H., Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol., 80, 535-561 (1981).
30. Snedecor, G. W. and Cochran, W. G., Statistical Methods, 6th ed., Iowa State University Press, Ames, pp. 1-593 (1967).
31. Vaes, G., A review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin. Orthop. Related Res., 231, 239-271 (1988).
32. Roodman, G. D., Interleukin-6: An osteotropic factor? J. Bone Miner. Res., 1, 475-478 (1992).
33. Barton, B. E. and Mayer, R., IL 3 and IL 6 do not induce bone resorption in vitro. Cytokine, 2, 217-220 (1990).
34. Al-Humidan, A., Ralston, S. H., Hughes, D. E., Chapman, K., Aarden, L., Russell, R. G. G., and Gowen, M., Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. J. Bone Miner. Res., 6, 3-8 (1991).
35. Delaisse, J. M., Ledent, P., and Vaes, G., Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase. Biochem. J., 279, 167-174 (1991).
36. Goto, T., Kiyoshima, T., Moroi, R., Tsukuba T., Nishimura, Y., Himeno, M., Yamamoto, K., and Tanaka, T., Localization of cathepsins B, D, and L in the rat osteoclast by immune-light and -electron microscopy. Histochemistry, 101, 33-40 (1994).
37. Goto, T., Tsukuba, T., Kiyoshima, T., Nishimura, Y., Kato, K., Yamamoto, K., and Tanaka, T., Immunohistochemical localization of cathepsins B, D, L in the rat osteoclasts. Histochemistry, 99, 411-414 (1993).
38. Hill, P. A., Buttle, D. J., Jones, S. J., Boyde, A., Murata, M., Reynold, J. J., and Meikle, M. C., Inhibition of bone resorption by selective inactivators of cysteine proteinases. J. Cell Biochem., 56, 118-130 (1994).
39. Katunuma, N., Participation of lysosomal cathepsins in antigen processing and bone resorption, In “Biological Functions of Proteases and Inhibitors,” eds. Katunuma, N., Suzuki, K., Travis, J., and Fritz, H., Japan Scientific Society Press, Tokyo, pp. 3-21 (1994).
40. Harris, E. D., Jr. and Cartwright, E. C., Mammalian col-lagenases, In “Proteinases in mammalian cells and tissues,” ed. Barrett, A. J., North-Holland Publishers, Amsterdam, pp. 249-283 (1977).
41. Barrett, A. J. and McDonald, K. J., Mammalian proteases: a glossary and bibliography, Vol. I, Endopeptidases, Academic Press, London, New York (1980).
42. Welgus, H. G., Jeffrey, J. J., and Eisen, A. Z., The collagen substrate specificity of human skin fibroblast collagenase. J. Biol. Chem., 256, 9511-9515 (1981).
43. Lamkin, M. S., Colclasure, C., Lloyd, J. M., Gonerman, W., Schmid, K., and Nimberg, R. B., Purification and partial characterization of a 52,000 dalton glycoprotein from human cancer ascites fluid which stimulates bone resorption in vitro. Cancer Res., 46, 4650-4655 (1986).
44. Lamkin, M., Colclasure, C., Rodrick, M., Troxler, R. M., Offner, G. D., Lloyd, W. S., Schmid, K., and Nimberg, R. B., Three forms of BRF-2 (Bone Resorptive Proteins) from human cancer asites fluid and their relationship to human serum Alpha-2 HS-glycoprotein. Calcif. Tissue Int., 41, 171-175 (1987).
45. 2-HS glycoprotein. FEBS Lett., 214, 45-49 (1987).
46. 2-HS glycoprotein and relation to other members of the cystatin superfamily. J. Biol. Chem., 265, 4354-4357 (1990).
47. Dziegielewska, K. M. and Brown, W. M., Fetuin in plasma and cerebrospinal fluid. In “Fetuin,” eds. Dziegielewska, K. M. and Brown, W. M., Springer-Verlag, New York, pp. 103-121 (1995).
48. 2-HS glycoprotein in mineralizing human bone. Nature, 256, 430-432 (1975).
49. 2-HS glycoprotein. Calcif. Tissue Res., 22, 27-33 (1976).
50. 2-HS glycoprotein, cel acid-glycoprotein, and IgE. Calcif. Tissue Int., 34, 229-231 (1982).
51. Pietschmann, P., Farsoudi, K. H., Hoffmann, O., Klaushofer, K., Horandner, H., and Peterlik, M., Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria. Bone, 14, 167-172 (1993).
52. Perry, H. M., Ill and Gurbani, S., Development of monoclonal antibodies to parathyroid hormone induced resorptive factors from osteoblast-like cells. Calcif. Tissue Int., 50, 237-244 (1992).
53. Greenfield, E. M., Gornik, S. A., Horowitz, M. C., Donahue, H. J., and Shaw, S. M., Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleu-kin-6 and leukemia inhibitory factor mRNA. J. Bone Miner. Res., 8, 1163-1171 (1993).
54. Nussbaum, S. R., Zahradnik, R. J., Lavigne, J. R., Brennam, G. L., Nozawα-Ung, K., Kim, L. Y., Keutmann, H. T., Wang, C. A., Potts, J. T., Jr, and Segre, G. V., Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin. Chem., 33, 1364-1367 (1987).
55. Dziegielewska, K. M. and Brown, W. M., Structure of the fetuins. In “Fetuin,” eds. Dziegielewska, K. M. and Brown, W. M., Springer-Verlag, New York, pp. 11-42 (1995).
56. Kessler, E. and Adar, R., Type I procollagen C-proteinase from mouse fibroblasts: purification and demonstration of a 55-kDa enhancer glycoprotein. Eur. J. Biochem., 186, 115-121 (1989).
57. Katunuma, N., Molecular mechanisms of bone collagen degradation in bone resorption. J. Bone Miner. Metab., 15, 1-8 (1997).
58. Tezuka, K., Tezuka, Y., Maejima, A., Sato, T., Nemoto, K., Kamioka, H., Hakeda, Y., and Kumegawa, M. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem., 269, 1106-1109 (1994).
59. Drake, F. H., Dodds, R. A., James, I. E., Connor, J. R., Debouck, C., Richrdson, S., Lee-Rykaczewski, E., Coleman, L., Rieman, D., Barthlow, R., Hastings, G., and Go wen, M., Cathepsin K, but not cathepsins B, L, or S, is abundently expressed in human osteoclasts. J. Biol. Chem., 271, 12511-12516 (1996).
60. Bossard, M. J., Tomaszek, T. A., Thompson, S. K., Amegadrizie, B. Y., Hanninng, C. R., Jones, C, Kurdyla, J. T., McMulty, D. E., Drake, F. H., Gowen, M., and Levy, M. A., Proteolytic activity of human osteoclast cathepsin K: expression, purification, activation, and substrate identification. J. Biol. Chem., 271, 12517-12524 (1996).
61. Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde, A., Rommerskirch, W., Moritz, J. D., Schu, P., and von Figura, K. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. U.S.A., 95, 13453-13458 (1998).